Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
Open claims and closed payer claims data are essential for understanding the status and activities of patients along their healthcare journey, but which data type is most useful and when? With HealthVerity and Symphony Health now coming together,...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Understanding how the IRA’s multiple provisions interact to induce cost-related change The Inflation Reduction Act (IRA) ushers in numerous changes for the pharmaceutical sector. The law is recognizable for its two headliner provisions: Mandated Part...